Andere Sprachen Nanalysis Scientific Corp.

Aktien

A2PNDW

CA63000Y1034

NSCI

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:21:44 03.05.2024			% 5 Tage	% 1. Jan.
0.44 ^CAD	+7.32%		0.00%	+17.33%

30.04.	Transcript : Nanalysis Scientific Corp., 2023 Earnings Call, Apr 30, 2024
29.04.	Nanalysis Scientific Corp. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Nanalysis Scientific Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	29.04.
Nanalysis Announces Fourth Quarter and Full Year 2023 Results	29.04.
/C O R R E C T I O N -- Nanalysis Scientific Corp./	24.04.
/C O R R E C T I O N -- Nanalysis Scientific Corp./	11.04.
Nanalysis Scientific Corp. Announces Director Resignation	10.04.
Nanalysis Scientific Corp. Announces Director Resignation	10.04.
Nanalysis Scientific Corp. Announces Resignation of Kham Lin as A Director	10.04.
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances	04.04.
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances	04.04.
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances	04.04.
NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND CONCURRENT PRIVATE PLACEMENT	20.03.
Nanalysis Scientific Corp. announced that it has received CAD 1 million in funding	20.03.
Nanalysis Scientific Announces Financings	06.03.
Canadian Investment Regulatory Organization Trading Halt - NSCI	06.03.
Nanalysis Scientific Brief: Announcing Up to $5 Million 'Best Efforts Prospectus Exempt Offering' Pursuant to the Listed Issuer Exemption and Up to $1 Million Concurrent Private Placement	06.03.
NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT	06.03.
Nanalysis Scientific Corp. announced that it expects to receive CAD 1 million in funding	06.03.
Nanalysis Scientific Corp. to Seeks Acquisitions	13.02.
Nanalysis Scientific Corp. Provides Earnings Guidance for the Fourth Quarter 2023	06.02.
Nanalysis Scientific Corp. Announces Grant of Restricted Share Units	04.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nanalysis Scientific Corp.

Aktien

A2PNDW

CA63000Y1034

NSCI

Andere Sprachen

Filter